Format

Send to

Choose Destination
Curr Med Chem. 2019 Aug 8. doi: 10.2174/0929867326666190808122929. [Epub ahead of print]

Recent Progress of benzimidazole hybrids for anticancer potential.

Author information

1
Department of Pharmaceutical Chemistry, School of Pharmaceutical Education & Research, Hamdard University, Hamdard Nagar, New Delhi-110062. India.
2
School of Pharmacy, Bharat Institute of Technology, NH58, Partapur Bypass Meerut-250103 . India.

Abstract

This review presented the detailed account of factors leading to cancer and design strategy for the synthesis of benzimidazole derivatives as anticancer agents. The recent survey for cancer treatment in Cancer facts and figures 2017 American Chemical society has shown progressive development in fighting cancer. Researchers all over the world in both the developed and developing countries are in continous effort to tackle this serious concern. Benzimidazole and its derivatives showed a broad range of biological activities due to their resemblance with natuarally occurring nitrogenous base i.e purine. The review discussed about benzimidazole derivatives showing anticancer properties through different mechanism viz. intercalation, alkylating agents, topoisomerases, DHFR enzymes and tubulin inhibitors. Benzimidazole derivatives act through different mechanism and the substituents reported from the earlier and recent research articles are prerequisites for synthesis of targeted based benzimidazole derivatives as anticancer agents. The review focuses on easy comparison of the substituent essential for potency and selectivity through SAR presented in figures. This will further provide better outlook or fulfills the challenges faced in the development of novel benzimidazole derivatives as anticancer.

KEYWORDS:

Benzimidazole; Cancer; Protein kinase inhibitors; SAR; angiogenesis; metastasis

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd.
Loading ...
Support Center